Delivery Order SPE2DB22D3102-SPE2DB24FL2HC
Award Date
8/1/24
Potential Completion Date
8/2/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OLOPATADINE HCL 0.1% EYE DROPS 5ML. The firm-fixed-price delivery order, valued at $1,115.33, has a completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical as a primary vehicle for providing a wide range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,424.20 delivery order is for the supply of Olopatadine HCL 0.1% eye drops in 5ml containers. The contract has a firm fixed price pricing type and an ultimate completion date of October 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Olopatadine Hydrochloride 0.1% eye drops. The $1,297.14 delivery order is a firm-fixed price contract with an ultimate completion date of April 24, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,995.95, is for the delivery of Olopatadine Hydrochloride 0.1% eye drops in 5 milliliter vials. This contract is a delivery order and has a firm fixed price. The ultimate completion date for this contract is October 11, 2024. This contract award is not associated with any...
This federal contract award, valued at $1,911.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4559605390 - Olopatadine HCL 0.1% Eye Drops 5ml. The contract has a firm fixed-price delivery order pricing type and an ultimate completion date of January 17, 2023. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running...
The federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, is for the delivery of olopatadine hydrochloride 0.1% eye drops in 5ml vials. The $4,862.96 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on November 27, 2024, with a completion date of November 29, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,370.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Olopatadine Hydrochloride 0.1% Eye Drops, a prescription medication, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract is structured as a Delivery Order, with a Firm Fixed Price pricing type and an...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olopatadine HCl 0.1% eye drops in 5 ml containers, with a total ceiling value of $1,005.36. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,825.66 firm fixed price delivery order is for the supply of Olopatadine HCL 0.1% eye drops, a prescription ophthalmic medication. The contract has a period of performance through March 20, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on an...
This federal contract award, with ID SPE2DB20D3505|SPE2DB23FT6B6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4559721980 - Olopatadine HCL 0.1% eye drops (5 ml). The $2,844.70 firm fixed-price delivery order has a completion date of January 26, 2023 and was awarded on January 25, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and holds an...